BioSpace News Archive

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the launch of its Systematic HLA Epitope Ranking Pan Algorithm (SHERPA), the company’s proprietary, machine learning-based tool for the comprehensive identification and characterization of cancer neoantigens. Integrated into the Personalis® NeXT Platform™, SHERPA enables the development of new neoantigen-based diagnostic biomark

RTC Utilizes AT&T IoT Video Intelligence Solution with Hitachi Vantara Technology to Deliver Body Temperature Thermal Imaging Analysis

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced the pricing of a follow-on public offering of 8,125,000 ordinary shares at a public offering price of $8.00 per share for aggregate gross proceeds of $65.0 million, before deducting underwriting discounts and commissions and estimated offering expenses. In addition, Gamida Cell h

The Bio-Process Systems Alliance (BPSA), the international industry association of the single-use bio-processing industry, is pleased to announce it expanded its Board of Directors to 19 members to lead the organization in 2021/2022 during its recent election. These Board Members will serve staggered two-year terms. “Our

Positive and negative coronavirus swabs and associated de-identified medical data can accelerate researchers’ work on treatments and vaccines

Program supports specialized skill development of early-career physicians and researchers interested in studying sarcoidosis

Essence Group , a leading global IoT solutions provider, today announced it will showcase two advanced 5G-connected IoT devices at the upcoming CES that demonstrate the company’s position at th

The Lupus Research Alliance (LRA) congratulates GSK on the U.S. Food and Drug Administration (FDA) approval of belimumab (Benlysta ® ) as the first-ever treatment indicated specifically for adults with lupus nephritis (LN), a complication of systemic lupus erythematosus (SLE). Another milestone, this new indication is the only FDA appro

Regulatory News Transgene (Paris:TNG) today announced its financial reporting dates for 2021: March 10, 2021: 2020 Fiscal Year Results April 27, 2021: First Quarter 2021 Financial Results May 26, 2021: Annual Shareholders’ Meeting

Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, has successfully deployed an AR smart glasses-based remote training program globally utilizing Vuzix M400 Smart Glasses